Literature DB >> 18086398

Venous thromboembolism in critical illness in a community intensive care unit.

John G Muscedere1, Daren K Heyland, Deborah Cook.   

Abstract

BACKGROUND: Venous thromboembolism (VTE) can be a life-threatening complication of critical illness. Venous thromboembolism rates observed depend on the population studied, the screening modality used, and thromboprophylaxis prescribed. Few studies report on the rates of clinically diagnosed VTE in critically ill patients. The purpose of this study was to characterize the incidence of clinically diagnosed VTE, prophylactic strategies used, and diagnostic studies ordered in a critically ill population at a tertiary community intensive care unit (ICU), both during and after their ICU stay.
METHODS: We did a retrospective chart review of 600 consecutive critically ill patients admitted to a tertiary community ICU.
RESULTS: Fifty (8.3%) patients developed VTE over the course of their ICU and hospital stay (18 [3.0%] patients during their ICU stay and 32 [5.7% of 561 ICU survivors] patients after ICU discharge). By ICU admission diagnosis, most events occurred in neurosurgical patients, although this group comprised only 24.8% of the population. Across all subgroups, most VTE events occurred after ICU discharge. Intensive care unit patients received thromboprophylaxis 87.6% (95% confidence interval, 81.5-93.7) of the time spent in ICU. However, thromboprophylaxis was administered significantly less often after transfer to the ward compared with within the ICU (from 87.6% to 59.8%, P < .001).
CONCLUSION: The rates of clinically diagnosed VTE rates in critically ill patients are substantial. Venous thromboembolism occurs before, during, and after ICU discharge. Continued vigilance and thromboprophylaxis are warranted across the continuum of critical illness.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18086398     DOI: 10.1016/j.jcrc.2007.02.003

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  4 in total

1.  Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Susan R Kahn; Wendy Lim; Andrew S Dunn; Mary Cushman; Francesco Dentali; Elie A Akl; Deborah J Cook; Alex A Balekian; Russell C Klein; Hoang Le; Sam Schulman; M Hassan Murad
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  VTE Incidence and Risk Factors in Patients With Severe Sepsis and Septic Shock.

Authors:  David Kaplan; T Charles Casper; C Gregory Elliott; Shaohua Men; Robert C Pendleton; Larry W Kraiss; Andrew S Weyrich; Colin K Grissom; Guy A Zimmerman; Matthew T Rondina
Journal:  Chest       Date:  2015-11       Impact factor: 9.410

3.  Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit.

Authors:  François Lauzier; John Muscedere; Eric Deland; Demetrios Jim Kutsogiannis; Michael Jacka; Diane Heels-Ansdell; Mark Crowther; Rodrigo Cartin-Ceba; Michael J Cox; Nicole Zytaruk; Denise Foster; Tasnim Sinuff; France Clarke; Patrica Thompson; Steven Hanna; Deborah Cook
Journal:  Crit Care       Date:  2014-04-25       Impact factor: 9.097

4.  Risk of venous thromboembolism in a Swedish healthcare system during the COVID-19 pandemic: A retrospective cross-sectional study.

Authors:  Jens Wretborn; Matthias Jörg; Patrik Benjaminsson Nyberg; Daniel B Wilhelms
Journal:  J Am Coll Emerg Physicians Open       Date:  2021-09-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.